SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 193 filers reported holding SEATTLE GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $33,153,000 | +401.8% | 527,400 | +321.2% | 0.03% | +350.0% |
| Q4 2016 | $6,607,000 | +75.0% | 125,200 | +79.1% | 0.01% | +100.0% |
| Q3 2016 | $3,775,000 | -11.9% | 69,900 | -34.1% | 0.00% | -25.0% |
| Q2 2016 | $4,283,000 | -11.5% | 106,000 | -23.1% | 0.00% | 0.0% |
| Q1 2016 | $4,839,000 | +104.2% | 137,900 | +161.2% | 0.00% | +100.0% |
| Q4 2015 | $2,370,000 | +92.1% | 52,800 | +65.0% | 0.00% | +100.0% |
| Q3 2015 | $1,234,000 | -55.4% | 32,000 | -55.8% | 0.00% | -66.7% |
| Q2 2014 | $2,768,000 | -26.6% | 72,356 | -12.6% | 0.00% | -25.0% |
| Q1 2014 | $3,771,000 | -20.5% | 82,756 | -30.4% | 0.00% | 0.0% |
| Q4 2013 | $4,745,000 | +19.7% | 118,956 | +31.5% | 0.00% | 0.0% |
| Q3 2013 | $3,964,000 | -89.3% | 90,433 | -92.3% | 0.00% | -89.7% |
| Q2 2013 | $37,073,000 | – | 1,178,407 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |